The David V Valve-Sparing Root Replacement Provides Improved Survival Compared With Mechanical Valve-conduits in the Treatment of Young Patients With Aortic Root Pathology

Background Valve-sparing root replacement (VSRR) is an attractive therapy for aortic root aneurysms; however, there is a paucity of data comparing VSRR with conventional root replacement using a mechanical valve-conduit (MECH). This study evaluates and compares outcomes of VSRR and MECH. Methods A r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of thoracic surgery 2016-11, Vol.102 (5), p.1522-1530
Hauptverfasser: Esaki, Jiro, MD, PhD, Leshnower, Bradley G., MD, Binongo, Jose N., PhD, Lasanajak, Yi, MPH, McPherson, LaRonica, RN, Halkos, Michael E., MD, Guyton, Robert A., MD, Chen, Edward P., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1530
container_issue 5
container_start_page 1522
container_title The Annals of thoracic surgery
container_volume 102
creator Esaki, Jiro, MD, PhD
Leshnower, Bradley G., MD
Binongo, Jose N., PhD
Lasanajak, Yi, MPH
McPherson, LaRonica, RN
Halkos, Michael E., MD
Guyton, Robert A., MD
Chen, Edward P., MD
description Background Valve-sparing root replacement (VSRR) is an attractive therapy for aortic root aneurysms; however, there is a paucity of data comparing VSRR with conventional root replacement using a mechanical valve-conduit (MECH). This study evaluates and compares outcomes of VSRR and MECH. Methods A retrospective review from 2002 to 2015 at a US academic center identified 444 patients who underwent VSRR (282 patients) or MECH (162 patients). Propensity score matching was performed, based on 22 preoperative and intraoperative characteristics, and 87 matched pairs were identified. Results There was no difference in mean age between the groups (VSRR 45.0 years, MECH 44.2 years, p = 0.59). The incidence of Marfan syndrome (VSRR 10.3%, MECH 12.6%, p = 0.63), type A acute aortic dissection (VSRR 25.3%, MECH 27.6%, p = 0.73), reoperation (VSRR 23.0%, MECH 21.8%, p = 0.86), and arch replacement (VSRR 54.0%, MECH 52.9%, p =  0.88) were similar in both groups. Ejection fraction was similar (VSRR 52.8% ± 10.9%, MECH 52.4% ± 11.7%, p = 0.83). Operative mortality was 2.3% with VSRR and 8.0% with MECH ( p = 0.10). There were no significant differences in renal failure requiring dialysis (VSRR 1.1%, MECH 4.6%, p = 0.24), permanent neurologic dysfunction (VSRR 2.3%, MECH 6.9%, p = 0.16), and pacemaker implantation (VSRR 1.1%, MECH 1.1%, p = 0.99) between the groups. Survival at 7 years was significantly improved in patients who underwent VSSR (VSRR 85.5%, MECH 73.6%, p = 0.03). Conclusions In comparison with patients undergoing MECH, there is improved midterm survival among patients undergoing VSRR, with similar operative mortality and morbidity. For appropriately selected patients, VSRR provides an attractive and potentially superior alternative to MECH.
doi_str_mv 10.1016/j.athoracsur.2016.04.091
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1826708783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0003497516304271</els_id><sourcerecordid>1826708783</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-827727187b148516e189689c229f5c7bd9d3e2c5d5904d5907cfc4587b9e6eaa3</originalsourceid><addsrcrecordid>eNqNUk2P0zAQjRCILQt_AfnIJcF24ji5IC1dPlZaRLUtizhZrjPduiRxsZ1I_U38SSabBSROXPwx8-aN3zwnCWE0Y5SVrw-ZjnvntQmDzzhGMlpktGaPkgUTgqclF_XjZEEpzdOiluIseRbCAa8c00-TMy5zkReVWCQ_N3sgl3q0Dbklt7odIV0ftbf9HblxLpIbOLbaQAd9JCvvEAeBXHVHPEJD1oMf7ahbsnQdVmHkq4178gnMXvfWYGKmNK5vBhsDsT2J2HDjQcd7Trcj39yA3VY6WgyEmeHC-WjN_ITVpLV1d6fnyZOdbgO8eNjPky_v322WH9Przx-ulhfXqSlkHdOKS8klq-SWoURWAqvqsqoN5_VOGLlt6iYHbkQjalpMizQ7UwjE11CC1vl58mrmRZU_BghRdTYYaFvdgxuCYhUvJa1klSO0mqHGuxA87NTR2077k2JUTVapg_prlZqsUrRQaBWWvnzoMmw7aP4U_vYGAW9nAKDW0YJXweCIDDTWg4mqcfZ_urz5h8S09t6a73CCcHCD73GWiqnAFVXr6ctMP4aVOS1wivkvgs_BvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826708783</pqid></control><display><type>article</type><title>The David V Valve-Sparing Root Replacement Provides Improved Survival Compared With Mechanical Valve-conduits in the Treatment of Young Patients With Aortic Root Pathology</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Free E-Journal (出版社公開部分のみ)</source><source>Alma/SFX Local Collection</source><creator>Esaki, Jiro, MD, PhD ; Leshnower, Bradley G., MD ; Binongo, Jose N., PhD ; Lasanajak, Yi, MPH ; McPherson, LaRonica, RN ; Halkos, Michael E., MD ; Guyton, Robert A., MD ; Chen, Edward P., MD</creator><creatorcontrib>Esaki, Jiro, MD, PhD ; Leshnower, Bradley G., MD ; Binongo, Jose N., PhD ; Lasanajak, Yi, MPH ; McPherson, LaRonica, RN ; Halkos, Michael E., MD ; Guyton, Robert A., MD ; Chen, Edward P., MD</creatorcontrib><description>Background Valve-sparing root replacement (VSRR) is an attractive therapy for aortic root aneurysms; however, there is a paucity of data comparing VSRR with conventional root replacement using a mechanical valve-conduit (MECH). This study evaluates and compares outcomes of VSRR and MECH. Methods A retrospective review from 2002 to 2015 at a US academic center identified 444 patients who underwent VSRR (282 patients) or MECH (162 patients). Propensity score matching was performed, based on 22 preoperative and intraoperative characteristics, and 87 matched pairs were identified. Results There was no difference in mean age between the groups (VSRR 45.0 years, MECH 44.2 years, p = 0.59). The incidence of Marfan syndrome (VSRR 10.3%, MECH 12.6%, p = 0.63), type A acute aortic dissection (VSRR 25.3%, MECH 27.6%, p = 0.73), reoperation (VSRR 23.0%, MECH 21.8%, p = 0.86), and arch replacement (VSRR 54.0%, MECH 52.9%, p =  0.88) were similar in both groups. Ejection fraction was similar (VSRR 52.8% ± 10.9%, MECH 52.4% ± 11.7%, p = 0.83). Operative mortality was 2.3% with VSRR and 8.0% with MECH ( p = 0.10). There were no significant differences in renal failure requiring dialysis (VSRR 1.1%, MECH 4.6%, p = 0.24), permanent neurologic dysfunction (VSRR 2.3%, MECH 6.9%, p = 0.16), and pacemaker implantation (VSRR 1.1%, MECH 1.1%, p = 0.99) between the groups. Survival at 7 years was significantly improved in patients who underwent VSSR (VSRR 85.5%, MECH 73.6%, p = 0.03). Conclusions In comparison with patients undergoing MECH, there is improved midterm survival among patients undergoing VSRR, with similar operative mortality and morbidity. For appropriately selected patients, VSRR provides an attractive and potentially superior alternative to MECH.</description><identifier>ISSN: 0003-4975</identifier><identifier>EISSN: 1552-6259</identifier><identifier>DOI: 10.1016/j.athoracsur.2016.04.091</identifier><identifier>PMID: 27353485</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Adult ; Aneurysm, Dissecting - surgery ; Aortic Aneurysm - etiology ; Aortic Aneurysm - surgery ; Aortic Valve - surgery ; Blood Vessel Prosthesis Implantation ; Cardiac Catheterization - methods ; Cardiothoracic Surgery ; Comorbidity ; Coronary Vessels - surgery ; Female ; Follow-Up Studies ; Heart Valve Prosthesis ; Heart Valve Prosthesis Implantation ; Humans ; Male ; Marfan Syndrome - complications ; Middle Aged ; Organ Sparing Treatments - methods ; Organ Sparing Treatments - mortality ; Propensity Score ; Replantation ; Research Design ; Retrospective Studies ; Surgery ; Suture Techniques</subject><ispartof>The Annals of thoracic surgery, 2016-11, Vol.102 (5), p.1522-1530</ispartof><rights>The Society of Thoracic Surgeons</rights><rights>2016 The Society of Thoracic Surgeons</rights><rights>Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-827727187b148516e189689c229f5c7bd9d3e2c5d5904d5907cfc4587b9e6eaa3</citedby><cites>FETCH-LOGICAL-c479t-827727187b148516e189689c229f5c7bd9d3e2c5d5904d5907cfc4587b9e6eaa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.athoracsur.2016.04.091$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27353485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Esaki, Jiro, MD, PhD</creatorcontrib><creatorcontrib>Leshnower, Bradley G., MD</creatorcontrib><creatorcontrib>Binongo, Jose N., PhD</creatorcontrib><creatorcontrib>Lasanajak, Yi, MPH</creatorcontrib><creatorcontrib>McPherson, LaRonica, RN</creatorcontrib><creatorcontrib>Halkos, Michael E., MD</creatorcontrib><creatorcontrib>Guyton, Robert A., MD</creatorcontrib><creatorcontrib>Chen, Edward P., MD</creatorcontrib><title>The David V Valve-Sparing Root Replacement Provides Improved Survival Compared With Mechanical Valve-conduits in the Treatment of Young Patients With Aortic Root Pathology</title><title>The Annals of thoracic surgery</title><addtitle>Ann Thorac Surg</addtitle><description>Background Valve-sparing root replacement (VSRR) is an attractive therapy for aortic root aneurysms; however, there is a paucity of data comparing VSRR with conventional root replacement using a mechanical valve-conduit (MECH). This study evaluates and compares outcomes of VSRR and MECH. Methods A retrospective review from 2002 to 2015 at a US academic center identified 444 patients who underwent VSRR (282 patients) or MECH (162 patients). Propensity score matching was performed, based on 22 preoperative and intraoperative characteristics, and 87 matched pairs were identified. Results There was no difference in mean age between the groups (VSRR 45.0 years, MECH 44.2 years, p = 0.59). The incidence of Marfan syndrome (VSRR 10.3%, MECH 12.6%, p = 0.63), type A acute aortic dissection (VSRR 25.3%, MECH 27.6%, p = 0.73), reoperation (VSRR 23.0%, MECH 21.8%, p = 0.86), and arch replacement (VSRR 54.0%, MECH 52.9%, p =  0.88) were similar in both groups. Ejection fraction was similar (VSRR 52.8% ± 10.9%, MECH 52.4% ± 11.7%, p = 0.83). Operative mortality was 2.3% with VSRR and 8.0% with MECH ( p = 0.10). There were no significant differences in renal failure requiring dialysis (VSRR 1.1%, MECH 4.6%, p = 0.24), permanent neurologic dysfunction (VSRR 2.3%, MECH 6.9%, p = 0.16), and pacemaker implantation (VSRR 1.1%, MECH 1.1%, p = 0.99) between the groups. Survival at 7 years was significantly improved in patients who underwent VSSR (VSRR 85.5%, MECH 73.6%, p = 0.03). Conclusions In comparison with patients undergoing MECH, there is improved midterm survival among patients undergoing VSRR, with similar operative mortality and morbidity. For appropriately selected patients, VSRR provides an attractive and potentially superior alternative to MECH.</description><subject>Adult</subject><subject>Aneurysm, Dissecting - surgery</subject><subject>Aortic Aneurysm - etiology</subject><subject>Aortic Aneurysm - surgery</subject><subject>Aortic Valve - surgery</subject><subject>Blood Vessel Prosthesis Implantation</subject><subject>Cardiac Catheterization - methods</subject><subject>Cardiothoracic Surgery</subject><subject>Comorbidity</subject><subject>Coronary Vessels - surgery</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart Valve Prosthesis</subject><subject>Heart Valve Prosthesis Implantation</subject><subject>Humans</subject><subject>Male</subject><subject>Marfan Syndrome - complications</subject><subject>Middle Aged</subject><subject>Organ Sparing Treatments - methods</subject><subject>Organ Sparing Treatments - mortality</subject><subject>Propensity Score</subject><subject>Replantation</subject><subject>Research Design</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Suture Techniques</subject><issn>0003-4975</issn><issn>1552-6259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUk2P0zAQjRCILQt_AfnIJcF24ji5IC1dPlZaRLUtizhZrjPduiRxsZ1I_U38SSabBSROXPwx8-aN3zwnCWE0Y5SVrw-ZjnvntQmDzzhGMlpktGaPkgUTgqclF_XjZEEpzdOiluIseRbCAa8c00-TMy5zkReVWCQ_N3sgl3q0Dbklt7odIV0ftbf9HblxLpIbOLbaQAd9JCvvEAeBXHVHPEJD1oMf7ahbsnQdVmHkq4178gnMXvfWYGKmNK5vBhsDsT2J2HDjQcd7Trcj39yA3VY6WgyEmeHC-WjN_ITVpLV1d6fnyZOdbgO8eNjPky_v322WH9Przx-ulhfXqSlkHdOKS8klq-SWoURWAqvqsqoN5_VOGLlt6iYHbkQjalpMizQ7UwjE11CC1vl58mrmRZU_BghRdTYYaFvdgxuCYhUvJa1klSO0mqHGuxA87NTR2077k2JUTVapg_prlZqsUrRQaBWWvnzoMmw7aP4U_vYGAW9nAKDW0YJXweCIDDTWg4mqcfZ_urz5h8S09t6a73CCcHCD73GWiqnAFVXr6ctMP4aVOS1wivkvgs_BvA</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Esaki, Jiro, MD, PhD</creator><creator>Leshnower, Bradley G., MD</creator><creator>Binongo, Jose N., PhD</creator><creator>Lasanajak, Yi, MPH</creator><creator>McPherson, LaRonica, RN</creator><creator>Halkos, Michael E., MD</creator><creator>Guyton, Robert A., MD</creator><creator>Chen, Edward P., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20161101</creationdate><title>The David V Valve-Sparing Root Replacement Provides Improved Survival Compared With Mechanical Valve-conduits in the Treatment of Young Patients With Aortic Root Pathology</title><author>Esaki, Jiro, MD, PhD ; Leshnower, Bradley G., MD ; Binongo, Jose N., PhD ; Lasanajak, Yi, MPH ; McPherson, LaRonica, RN ; Halkos, Michael E., MD ; Guyton, Robert A., MD ; Chen, Edward P., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-827727187b148516e189689c229f5c7bd9d3e2c5d5904d5907cfc4587b9e6eaa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aneurysm, Dissecting - surgery</topic><topic>Aortic Aneurysm - etiology</topic><topic>Aortic Aneurysm - surgery</topic><topic>Aortic Valve - surgery</topic><topic>Blood Vessel Prosthesis Implantation</topic><topic>Cardiac Catheterization - methods</topic><topic>Cardiothoracic Surgery</topic><topic>Comorbidity</topic><topic>Coronary Vessels - surgery</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart Valve Prosthesis</topic><topic>Heart Valve Prosthesis Implantation</topic><topic>Humans</topic><topic>Male</topic><topic>Marfan Syndrome - complications</topic><topic>Middle Aged</topic><topic>Organ Sparing Treatments - methods</topic><topic>Organ Sparing Treatments - mortality</topic><topic>Propensity Score</topic><topic>Replantation</topic><topic>Research Design</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Suture Techniques</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Esaki, Jiro, MD, PhD</creatorcontrib><creatorcontrib>Leshnower, Bradley G., MD</creatorcontrib><creatorcontrib>Binongo, Jose N., PhD</creatorcontrib><creatorcontrib>Lasanajak, Yi, MPH</creatorcontrib><creatorcontrib>McPherson, LaRonica, RN</creatorcontrib><creatorcontrib>Halkos, Michael E., MD</creatorcontrib><creatorcontrib>Guyton, Robert A., MD</creatorcontrib><creatorcontrib>Chen, Edward P., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Esaki, Jiro, MD, PhD</au><au>Leshnower, Bradley G., MD</au><au>Binongo, Jose N., PhD</au><au>Lasanajak, Yi, MPH</au><au>McPherson, LaRonica, RN</au><au>Halkos, Michael E., MD</au><au>Guyton, Robert A., MD</au><au>Chen, Edward P., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The David V Valve-Sparing Root Replacement Provides Improved Survival Compared With Mechanical Valve-conduits in the Treatment of Young Patients With Aortic Root Pathology</atitle><jtitle>The Annals of thoracic surgery</jtitle><addtitle>Ann Thorac Surg</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>102</volume><issue>5</issue><spage>1522</spage><epage>1530</epage><pages>1522-1530</pages><issn>0003-4975</issn><eissn>1552-6259</eissn><abstract>Background Valve-sparing root replacement (VSRR) is an attractive therapy for aortic root aneurysms; however, there is a paucity of data comparing VSRR with conventional root replacement using a mechanical valve-conduit (MECH). This study evaluates and compares outcomes of VSRR and MECH. Methods A retrospective review from 2002 to 2015 at a US academic center identified 444 patients who underwent VSRR (282 patients) or MECH (162 patients). Propensity score matching was performed, based on 22 preoperative and intraoperative characteristics, and 87 matched pairs were identified. Results There was no difference in mean age between the groups (VSRR 45.0 years, MECH 44.2 years, p = 0.59). The incidence of Marfan syndrome (VSRR 10.3%, MECH 12.6%, p = 0.63), type A acute aortic dissection (VSRR 25.3%, MECH 27.6%, p = 0.73), reoperation (VSRR 23.0%, MECH 21.8%, p = 0.86), and arch replacement (VSRR 54.0%, MECH 52.9%, p =  0.88) were similar in both groups. Ejection fraction was similar (VSRR 52.8% ± 10.9%, MECH 52.4% ± 11.7%, p = 0.83). Operative mortality was 2.3% with VSRR and 8.0% with MECH ( p = 0.10). There were no significant differences in renal failure requiring dialysis (VSRR 1.1%, MECH 4.6%, p = 0.24), permanent neurologic dysfunction (VSRR 2.3%, MECH 6.9%, p = 0.16), and pacemaker implantation (VSRR 1.1%, MECH 1.1%, p = 0.99) between the groups. Survival at 7 years was significantly improved in patients who underwent VSSR (VSRR 85.5%, MECH 73.6%, p = 0.03). Conclusions In comparison with patients undergoing MECH, there is improved midterm survival among patients undergoing VSRR, with similar operative mortality and morbidity. For appropriately selected patients, VSRR provides an attractive and potentially superior alternative to MECH.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>27353485</pmid><doi>10.1016/j.athoracsur.2016.04.091</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4975
ispartof The Annals of thoracic surgery, 2016-11, Vol.102 (5), p.1522-1530
issn 0003-4975
1552-6259
language eng
recordid cdi_proquest_miscellaneous_1826708783
source MEDLINE; Elsevier ScienceDirect Journals Complete; Free E-Journal (出版社公開部分のみ); Alma/SFX Local Collection
subjects Adult
Aneurysm, Dissecting - surgery
Aortic Aneurysm - etiology
Aortic Aneurysm - surgery
Aortic Valve - surgery
Blood Vessel Prosthesis Implantation
Cardiac Catheterization - methods
Cardiothoracic Surgery
Comorbidity
Coronary Vessels - surgery
Female
Follow-Up Studies
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation
Humans
Male
Marfan Syndrome - complications
Middle Aged
Organ Sparing Treatments - methods
Organ Sparing Treatments - mortality
Propensity Score
Replantation
Research Design
Retrospective Studies
Surgery
Suture Techniques
title The David V Valve-Sparing Root Replacement Provides Improved Survival Compared With Mechanical Valve-conduits in the Treatment of Young Patients With Aortic Root Pathology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A41%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20David%20V%20Valve-Sparing%20Root%20Replacement%20Provides%20Improved%20Survival%20Compared%20With%20Mechanical%20Valve-conduits%20in%20the%20Treatment%20of%20Young%20Patients%20With%20Aortic%20Root%20Pathology&rft.jtitle=The%20Annals%20of%20thoracic%20surgery&rft.au=Esaki,%20Jiro,%20MD,%20PhD&rft.date=2016-11-01&rft.volume=102&rft.issue=5&rft.spage=1522&rft.epage=1530&rft.pages=1522-1530&rft.issn=0003-4975&rft.eissn=1552-6259&rft_id=info:doi/10.1016/j.athoracsur.2016.04.091&rft_dat=%3Cproquest_cross%3E1826708783%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826708783&rft_id=info:pmid/27353485&rft_els_id=S0003497516304271&rfr_iscdi=true